top of page
Clinical Trials
Trials are being held to evaluate the efficacy of HSCT for MS.
MIST
MIST is the first ever international large scale randomised trial into autologous haematopoietic stem cell transplantation (AHSCT) in relapsing remitting multiple sclerosis (MS)
Read More
bottom of page